Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling.

Saved in:
Bibliographic Details
Title: Homologous Recombination Deficiency as an Ovarian Cancer Biomarker in a Real-World Cohort: Validation of Decentralized Genomic Profiling.
Authors: Denkert C; Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany. Electronic address: carsten.denkert@uni-marburg.de., Romey M; Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany., Swedlund B; Myriad Genetics, Salt Lake City, Utah., Hattesohl A; Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany., Teply-Szymanski J; Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany., Kommoss S; Department of Women's Health, Tübingen University Hospital, Tübingen, Germany., Kaiser K; Myriad Genetics, Salt Lake City, Utah., Staebler A; Institute of Pathology, Tübingen University Hospital, Tübingen, Germany., du Bois A; Evangelische Kliniken Essen-Mitte, Essen, Germany., Grass A; Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany., Knappmeyer C; Myriad Genetics, Salt Lake City, Utah., Heitz F; Evangelische Kliniken Essen-Mitte, Essen, Germany; Department of Gynecology with the Centre of Oncologic Surgery Charite Campus, Virchow Klinikum, Charité Universitätsmedizin Berlin, Berlin, Germany., Solimeno C; Myriad Genetics, Salt Lake City, Utah., Ebel T; Essen, Germany., Harter P; Evangelische Kliniken Essen-Mitte, Essen, Germany., Marmé F; Department of Obstetrics and Gynaecology, University Hospital Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Jank P; Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany., Gaiser T; Institute of Pathology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany., Neff C; Myriad Genetics, Salt Lake City, Utah., Wagner U; Department of Gynecology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany., Timms KM; Myriad Genetics, Salt Lake City, Utah., Rodepeter F; Institute of Pathology, Philipps-Universität Marburg and University Hospital Marburg, Marburg, Germany.
Source: The Journal of molecular diagnostics : JMD [J Mol Diagn] 2022 Dec; Vol. 24 (12), pp. 1254-1263. Date of Electronic Publication: 2022 Sep 30.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 100893612 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1943-7811 (Electronic) Linking ISSN: 15251578 NLM ISO Abbreviation: J Mol Diagn Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1943-7811
DOI:10.1016/j.jmoldx.2022.09.004